Metabolism and excretion of digitoxin in man.

Suppr

超能文献

作者信息

Vöhringer H F, Rietbrock N

出版信息

Clin Pharmacol Ther. 1974 Nov;16(5 Part 1):796-806. doi: 10.1002/cpt1974165part1796.

DOI:10.1002/cpt1974165part1796

PMID:4426148

Abstract

摘要

相似文献

Metabolism and excretion of digitoxin in man.

Clin Pharmacol Ther. 1974 Nov;16(5 Part 1):796-806. doi: 10.1002/cpt1974165part1796.

Metabolism and excretion of 3H-digitoxin in the rat.

Biochem Pharmacol. 1974 Sep 15;23(18):2567-75. doi: 10.1016/0006-2952(74)90179-8.

Some aspects of the distribution and disposition of digitoxin in man.

Ann N Y Acad Sci. 1971 Jul 6;179:338-61. doi: 10.1111/j.1749-6632.1971.tb46912.x.

Influence of spironolactone pretreatment on pharmacokinetics and metabolism of digitoxin in rats.

Naunyn Schmiedebergs Arch Pharmacol. 1975;287(2):129-39. doi: 10.1007/BF00510445.

Proceedings: Influence of spironolactone pretreatment on pharmakokinetics and metabolism of digitoxin in the rat.

Naunyn Schmiedebergs Arch Pharmacol. 1974;282(Suppl):suppl 282:R102.

Disposition of digitoxin in renal failure.

Clin Pharmacol Ther. 1976 Apr;19(4):387-95. doi: 10.1002/cpt1976194387.

Studies on digitalis. IX. Some kinetic aspects of digitoxin metabolism.

Clin Pharmacol Ther. 1977 Mar;21(3):255-66. doi: 10.1002/cpt1977213255.

[Serum concentration and excretion of H3Y digitoxin in humans under normal and pathologic conditions].

Klin Wochenschr. 1969 Jul 1;47(13):695-700. doi: 10.1007/BF01881619.

Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.

J Clin Invest. 1971 Dec;50(12):2638-44. doi: 10.1172/JCI106764.

Pharmacokinetic and metabolic fate of potassium canrenoate (SC-14266) in man.

J Pharm Sci. 1971 May;60(5):708-15. doi: 10.1002/jps.2600600510.

引用本文的文献

Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment.

Eur J Clin Pharmacol. 1981 Jan;19(1):45-51. doi: 10.1007/BF00558383.

A standard approach to compiling clinical pharmacokinetic data.

J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343.

Clin Pharmacokinet. 1982 Sep-Oct;7(5):434-51. doi: 10.2165/00003088-198207050-00004.

Pharmacokinetics and bioavailability of digitoxin by a specific assay.

Eur J Clin Pharmacol. 1984;27(1):85-9.

Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.

Clin Pharmacokinet. 1983 Mar-Apr;8(2):155-78. doi: 10.2165/00003088-198308020-00003.

[Plasma concentrations and elimination of methyl proscillaridin in renal failure (author's transl)].

Klin Wochenschr. 1974 Nov 15;52(22):1078-81. doi: 10.1007/BF01468995.

Bioavailability of the bis- and monodigitoxosides of digitoxigenin.

Eur J Clin Pharmacol. 1985;28(6):649-52. doi: 10.1007/BF00607909.

Hydroxysteroid sulfotransferase and a specific UDP-glucuronosyltransferase are involved in the metabolism of digitoxin in man.

Naunyn Schmiedebergs Arch Pharmacol. 1992 Aug;346(2):226-33. doi: 10.1007/BF00165306.

Disposition of beta-methyldigoxin in man.

Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):105-14. doi: 10.1007/BF00614005.

Metabolism and excretion of methylproscillaridin by man.

Eur J Clin Pharmacol. 1975 Aug 14;8(6):427-32. doi: 10.1007/BF00562317.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验